Sonographic and Laboratory Evaluation of the Thyroid Gland in Patients With Systemic Sclerosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01270425 |
Recruitment Status :
Completed
First Posted : January 5, 2011
Last Update Posted : February 28, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Systemic sclerosis (SSc) is a systemic disease that involves various organs such as the skin, kidneys, gastrointestinal tract and lungs. Dysfunction of the thyroid gland is prevalent in these patients and may be related to thyroid fibrosis or to thyroid autoimmune disease, i.e. hashimoto's thyroiditis. Thyroid nodules are prevalent in the general population, although some reports suggest they might be more frequent in patients with SSc. Hashimoto's thyroiditis, by itself, carries a higher risk for thyroid nodules and thyroid cancer.
The aim of the study:To characterize sonographycally the thyroid gland of patients with SSc with and without Hashimoto's disease
Condition or disease |
---|
Systemic Sclerosis Hashimoto Thyroiditis Thyroid Nodules |
Study Type : | Observational |
Actual Enrollment : | 60 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Sonographic Characterization of the Thyroid Gland in Patients With Systemic Sclerosis With and Without Hashimoto Thyroiditis |
Study Start Date : | January 2011 |
Actual Primary Completion Date : | December 2011 |
Actual Study Completion Date : | November 2012 |

- There are no spesific outcome measures from trail [ Time Frame: Nnone ]the measures from trail are equal to vast population

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Clinical diagnosis of systemic sclerosis
Exclusion Criteria:
- non

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270425
Israel | |
Meir Medical Center | |
Kfar Saba, Israel |
Principal Investigator: | Pnina Rotman-Pikielny, MD | Meir Medical Center, Israel |
Responsible Party: | Meir Medical Center |
ClinicalTrials.gov Identifier: | NCT01270425 |
Other Study ID Numbers: |
MMC11175-10CTIL |
First Posted: | January 5, 2011 Key Record Dates |
Last Update Posted: | February 28, 2013 |
Last Verified: | March 2012 |
systemic sclerosis hashimoto thyroiditis thyroid nodules |
Thyroid Nodule Scleroderma, Systemic Scleroderma, Diffuse Thyroid Diseases Thyroiditis Hashimoto Disease Sclerosis Pathologic Processes Endocrine System Diseases |
Connective Tissue Diseases Skin Diseases Thyroid Neoplasms Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Head and Neck Neoplasms Thyroiditis, Autoimmune |